当前位置:产品中心 > 抗体 > 动物抗体 > Anti-Mouse Antibody > Anti-Mouse_PD1×VEGF hIgG1 Bispecific Antibody
Anti-Mouse_PD1×VEGF hIgG1 Bispecific Antibody
基本信息

产品编号:GM-88254MAB

产品名称:Anti-Mouse_PD1×VEGF hIgG1 Bispecific Antibody

目录价:询价

产品配图.jpg


规格货号

GM-88254MAB-1mg / 1 mg

GM-88254MAB-5mg / 5 mg

GM-88254MAB-25mg / 5 mg * 5 vials

GM-88254MAB-50mg / 50 mg

GM-88254MAB-100mg / 50 mg * 2 vials


产品简介

Expression System

CHO

Aggregation

< 5% as determined by SEC-HPLC

Purity

> 95% as determined by SDS-PAGE

Endotoxin

< 1 EU/mg, determined by LAL gel clotting assay

Sterility

0.2 μm Filtered

Target

VEGF&PD1

Alternative Names

PD1: CD279

VEGF: VPF; MVCD1; L-VEGF

Source/Isotype

Monoclonal human IgG1 D265A, Kappa

Application

Flow cytometry; Block assay

Description

PD-1/VEGF Bispesific Antibody is a novel cancer immunotherapy drug that can target both PD-1 and VEGF. It blocks the interaction between PD-1 and PD-L1/PD-L2. The bispecific antibody can specifically bind to VEGFA and PD-1, selectively relieve the immune suppression caused by VEGFA and PD-1 in the body, and inhibit tumor-induced angiogenesis.

Formulation

20 mM Histidine, 150 mM NaCl, pH6.0


数据展示

image.png

image.png

image.png

image.png

当前位置:产品中心 > 抗体 > 动物抗体 > Anti-Mouse_PD1×VEGF hIgG1 Bispecific Antibody

Anti-Mouse_PD1×VEGF hIgG1 Bispecific Antibody
基本信息

产品编号:GM-88254MAB

产品名称:Anti-Mouse_PD1×VEGF hIgG1 Bispecific Antibody

目录价:询价

产品配图.jpg


规格货号

GM-88254MAB-1mg / 1 mg

GM-88254MAB-5mg / 5 mg

GM-88254MAB-25mg / 5 mg * 5 vials

GM-88254MAB-50mg / 50 mg

GM-88254MAB-100mg / 50 mg * 2 vials


产品简介

Expression System

CHO

Aggregation

< 5% as determined by SEC-HPLC

Purity

> 95% as determined by SDS-PAGE

Endotoxin

< 1 EU/mg, determined by LAL gel clotting assay

Sterility

0.2 μm Filtered

Target

VEGF&PD1

Alternative Names

PD1: CD279

VEGF: VPF; MVCD1; L-VEGF

Source/Isotype

Monoclonal human IgG1 D265A, Kappa

Application

Flow cytometry; Block assay

Description

PD-1/VEGF Bispesific Antibody is a novel cancer immunotherapy drug that can target both PD-1 and VEGF. It blocks the interaction between PD-1 and PD-L1/PD-L2. The bispecific antibody can specifically bind to VEGFA and PD-1, selectively relieve the immune suppression caused by VEGFA and PD-1 in the body, and inhibit tumor-induced angiogenesis.

Formulation

20 mM Histidine, 150 mM NaCl, pH6.0


数据展示

image.png

image.png

image.png

image.png

Tel: 400-627-9288
留言咨询
重置
提交
客服
微信
电话
留言
留言咨询
重置
提交